
==== Front
ACS OmegaACS OmegaaoacsodfACS Omega2470-1343American Chemical Society 3145874910.1021/acsomega.8b00715ArticleOne-Pot Tandem Approach to
Functionalized 3-Hydroxy-2-furanyl-acrylamides Mupparapu Nagaraju †Khan Shahnawaz †‡Bandhoria Pankaj §Athimoolam Shunmuganarayanan ∥Ahmed Qazi Naveed *†‡† Medicinal
Chemistry Division, Indian Institute of
Integrative Medicine (IIIM), Jammu 180001, India‡ Academy
of Scientific and Innovative Research (AcSIR-IIIM), Jammu 180001, India§ Department
of Physics, GGM Science College, Jammu 180001, India∥ Department
of Physics, University College of Engineering Nagercoil, Anna University of Technology Tirunelveli, Nagercoil 629 004, India* E-mail: naqazi@iiim.ac.in.21 05 2018 31 05 2018 3 5 5445 5452 13 04 2018 07 05 2018 Copyright © 2018 American Chemical Society2018American Chemical SocietyThis is an open access article published under an ACS AuthorChoice License, which permits copying and redistribution of the article or any adaptations for non-commercial purposes.

A novel
one-pot tandem process involving Knoevenagel condensation,
Michael addition, selective amidation, and Paal–Knorr cyclization
to diverse functionalized 3-hydroxy-2-furanyl-acrylamides from simple
2-oxoaldehydes and aroylacetonitriles was presented. Attempts were
also made to expand the scope of the reaction to different 2-heteroarylfurans.
The packing diagram of the molecules viewed down along the α-axis
of the unit cell showed a characteristic intramolecular classical
O–H···O hydrogen bond between hydroxyl and carbonyl
O atoms leading to self-associated (Z)-2-furanyl-acrylamides.

document-id-old-9ao8b00715document-id-new-14ao-2018-00715vccc-price
==== Body
Introduction
Synthesis of diverse
heterocycles using readily available starting
materials is everlasting aim of synthetic organic chemistry. Especially
in recent years, under the inspiration of step economy, the use of
cascade reactions to achieve target products is attracting increasing
attention. In this context, tandem reactions which allow multiple
chemical transformations in one pot have been recognized as a rather
valuable strategy in realizing organic synthesis with high efficiency.1 Because of these significant advantages, tandem
reactions have been a popular strategy for the rapid synthesis of
small molecules, especially in the synthesis of drug like structures
and natural products.2

Multisubstituted
furans signify one of the important classes of
five-membered heterocycles prevalent in natural products, pharmaceuticals,
and agrochemicals and also represent useful intermediates in organic
synthesis.3 Consequently, a number of synthetic
routes for the construction of polysubstituted furans have been reported,
such as direct functionalization of furan rings,4 Paal–Knorr synthesis,5 Feist–Benary synthesis,6 and metal-catalyzed
cycloisomerization of alkynyl or allenyl substrates.7 However, the investigation of innovative methods for the
generation of polyfunctionalized furans is still highly desirable.
One of the core concepts involves the Wittig reaction between α-substituted
chalcones (generated from aldehydes) and acyl chlorides using a combination
of reagents (Scheme 1a).8 In an effort to develop such a system,
we hypothesized that the reaction of aroylacetonitrile 1 with 2-oxoaldehydes (OAs) 2 under triethylamine (TEA)–tert-butyl hydroperoxide (TBHP) combination in one pot will
result in the synthesis of 3-cyanofurans, through an in situ generated
1,4-dione A (Scheme 1b).9 However, an unprecedented
reaction between 1 and 2 under TEA–TBHP
resulted in the synthesis of Z-selective highly functionalized polysubstituted
furans that are difficult to be accessed by other protocols (Scheme 1c). In this context,
we wish to present a new type of one-pot tandem reaction between aroylacetonitriles
and OAs for the generation of diverse functionalized 3-hydroxy-2-furanyl-acrylamides.
The salient feature of this reaction represents the TEA–TBHP-promoted
dual addition of acetonitriles against OAs.

Scheme 1 Synthesis of Highly
Functionalized Furans via a One-Pot Tandem Reaction
Results and Discussion
We commenced
our study by investigating the reaction of benzoylacetonitrile 1a (1 mmol), phenylglyoxal 2a (1 mmol), morpholine
(0.5 mmol), and TBHP (1.1 mmol) in toluene at 70 °C (entry 1, Table 1). To our delight,
the reaction furnished the desired furan 3a in 54% yield
and phenylglyoxylicacid 4a as a byproduct. Following
the promising results achieved with the above method, the reaction
conditions, particularly, the change in base, concentrations, and
temperature were investigated (entries 2–23). Preliminarily,
a survey of change in base (entries 1–6) intimated that best
results were observed with 0.5 mmol of TEA (entry 6). Besides, screening
of our reaction at different concentrations of TEA and TBHP was also
performed (entries 7–12). We observed that any change in the
concentration of base/TBHP resulted in a decrease of 3a. However, in the absence of TEA and TBHP, we found no reaction (entries
10 and 12). Furthermore, a survey of change in temperature (entries
13–16) intimated that the yields were drastically affected
by the increase/decrease in the reaction temperature. Reaction of 1a with 2a in most of the solvents (entries 17–21)
at 70 °C failed to produce 3a in good yields (except
for the reaction in CHCl3). Finally, two different reactions
when tested against different oxidants confirmed the role of TBHP
to promote our reaction (entries 22–23). In addition, we also
studied the effect of change in concentration of 2a and
TBHP on reaction yields (Table S1, page
SI3). It was quite evident that the increase in the concentration
of TBHP or the change in the optimal concentration of 2a led to formation of byproducts and hence resulted in lower yields
of 3a. After optimization studies, we observed that the
paramount conditions for the reaction were when 1 mmol of 1a was treated with 1 mmol of 2a, 0.5 mmol of TEA, and
1.1 mmol of TBHP in 2 mL of toluene at 70 °C (entry 3).

Table 1 Optimization for the Synthesis of
Functionalized 3-Hydroxy-2-furanyl-acrylamidesa
entry	base (mmol)	oxidant (mmol)	solvent	temp (°C)	yield 3a (%)b	
1	morpholine (0.5)	TBHP (1.1)	toluene	70	54	
2	piperidine (0.5)	”	”	”	35	
3	DBU (0.5)	”	”	”	39	
4	DABCO (0.5)	”	”	”	28	
5	DMAP (0.5)	”	”	”	10	
6	TEA (0.5)	”	”	”	76	
7	TEA (0.3)	”	”	”	45	
8	TEA (0.1)	”	”	”	25	
9	TEA (1.0)	”	”	”	15	
10	 	”	”	”	 	
11	TEA (0.5)	TBHP (0.5)	”	”	35	
12	”	 	”	”	 	
13	”	TBHP (1.1)	 	80	71	
14	”	”	”	90	43	
15	”	”	”	60	23	
16	”	”	”	rt	 	
17	”	”	dioxane	70	trace	
18	”	”	CHCl3	”	30	
19	”	”	DMF	”	 	
20	”	”	MeOH	”	 	
21	”	”	MeCN	”	 	
22	”	TEMPO (1.1)	toluene	”	 	
23	”	IBX (1.1)	toluene	”	 	
a Reaction conditions:
benzoylacetonitrile 1a (1.0 mmol), phenylglyoxal 2a (1.0 mmol) and
TEA (0.5 mmol), 5–6 M TBHP in decane (1.1 mmol) in toluene
at 70 °C.

b Isolated
yield.

The structure and
the Z-selectivity of our reactions were confirmed
by the single-crystal X-ray diffraction studies of 3n and 3f (Figure 1; for details, see the Supporting Information, pages SI5–SI11). The packing diagram of 3n viewed
down along the α-axis of the unit cell clearly features one
intramolecular classical O–H···O hydrogen bond
between hydroxyl and carbonyl O atoms leading to a self-associated
motif. Furthermore, the crystal structure is stabilized by classical
N–H···N hydrogen bonds (between amide and cyanide
groups) and nonclassical weak intermolecular C–H···O
interactions.

Figure 1 ORTEP and packing diagrams viewed down along the α-axis
of
the unit cell of 3n.

With the optimized reaction condition in hand, we next investigated
the substrate scope (Table 2). In one set of experiments, different reactions were performed
between benzoylacetonitrile 1a and OAs 2 (entries 3a–3l). Various aromatic OAs proceeded
well in this process, and valuable functional groups such as chloro,
bromo, fluoro, CF3, hydoxy, methyl, ethyl, and nitro were
tolerated. Furthermore, substituents at different positions of the
arene group and their electronic nature do not affect the efficiency
of the reaction to that extent, even though we observed comparatively
lower yields with electron-withdrawing groups (entries 3e and 3f). Another set of experiments were performed
between different acetonitriles 1 and phenylglyoxal 2a (entries 3m–3p) for the preparation
of different furans 3. Yields were generally good for
all tested reactions. After having established the scope of the reaction,
a small library of different 3-hydroxy-2-furanyl-acrylamides were
also produced by assembling the building blocks shown in Table 2 (entries 3q–3u).

Table 2 Substrate Scope for the Functionalized
3-Hydroxy-2-furanyl-acrylamidesa
a Reaction conditions: 1 (0.689 mmol), 2 (0.689 mmol), and TEA (0.344 mmol),
5–6 M TBHP in decane (0.758 mmol) in toluene at 70 °C.

b Isolated yield.

Further, we proposed to extend the
application of our method toward
the generation of different 2-heteroarylfurans, which may be useful
in medicinal or materials science.10 This
characteristic feature of the reaction could be helpful to generate
different valuable structures, which otherwise are difficult to be
generated through previous approaches.4−8 In all of these presumptions, the nature of heteroarylglyoxals 2 decides the fate of the furan-heteroaryl coupling product.
For instance, different reactions tested between aroylacetonitriles 1 and 2-thiopheneglyoxals 2 resulted in the generation
of different 2-(thiophen-2-yl)furans (entries 3v–3aa, Table 3). We were
gratified to find that in all tested reactions, the desired products 3 were isolated in appreciable yields (46–65%).

Table 3 Substrate Scope for the Functionalized
2-(Thiophen-2-yl)-furansa
a Reaction conditions: 1 (0.689 mmol), 2 (0.689 mmol), and TEA (0.344 mmol),
5–6 M TBHP in decane (0.758 mmol) in toluene at 70 °C.

b Isolated yield.

In order to investigate the mechanism
of synthesis of (Z)-2-furanyl-acrylamides, different
controlled experiments
were performed (Figure 2a). Experiment 1, conducted between 1b with 2a in the presence of free-radical scavenger (TEMPO, 4 equiv) under
the optimized conditions, resulted in the synthesis of 3m in comparable yields, thereby excluding the possibility of free-radical
pathway. Our reaction when performed in the presence of either TBHP
or TEA (experiments 2 and 3) failed to produce the desired product 3m. These two results demonstrate that the second addition/cyclization
to 3m involves participation of both the reagents. Further,
the reaction of phenylglyoxal in the presence of TBHP in toluene at
70 °C generated acid 5 in good yields (experiment
4). These findings along with the optimization observation “entry
3 (Table 1, isolation
of oxoacid 4a)” undoubtedly emphasize the role
of in situ generated acid in the Paal–Knorr cyclization and
the consumption of half mole of oxoaldehydes in our reaction. In continuation,
we performed a reaction between intermediate 6(9) and toluoylacetonitrile under optimized conditions
in the presence of 2-oxoacid 5 (experiment 5). The formation
of the desired product in comparable yields pointed toward the participation
of Michael acceptor A in the reaction. Finally, the failure
of reaction with aliphatic glyoxal/acetonitrile under the described
conditions justifies the participation of the aryl group in the activation
of intermediate A (experiment 6).

Figure 2 (a) Control experiment
and (b) plausible mechanism.

On the basis of the preceding literature reports5 and the abovementioned results, a plausible reaction
mechanism
is proposed in Figure 2b. The initial step for the synthesis of 3-hydroxy-2-furanyl-acrylamides 3 involves the reaction of aroylacetonitrile 1 and OA 2 under a basic environment to form Knoevenagel
adduct or Michael acceptor A. This intermediate under
a TEA–TBHP environment undergoes second addition of aroylacetonitrile 1 to a symmetric resonance-stabilized Michael adduct B. Intermediate B in the presence of in situ
generated 2-oxoacid and TBHP experiences monoamidation to C. Finally, it undergoes the intramolecular Paal–Knorr cyclization
to required 3-hydroxy-2-furanyl-acrylamides 3.

Conclusions
We have outlined a new one-pot tandem approach for the generation
of 3-hydroxy-2-furanyl-acrylamides 3 through an unprecedented
reaction between aroylacetonitrile 1 and OA 2 under a TEA–TBHP environment. Despite the variation in the
nature of 1 and 2, the furans generated
had a functional core structure with Z-selective C-2 acrylamides.
These protocols also provided applications toward the generation of
different 2-heteroarylfurans in good yields. The stability of Z-isomer
in each case was attributed to the characteristic intramolecular classical
O–H···O hydrogen bond between hydroxyl and carbonyl
O atoms that led to self-associated (Z)-2-furanyl-acrylamides.

Experimental
Section
General Experiments
All chemicals used were of commercial
grade and were used as such. 1H NMR and 13C
NMR spectra were recorded on 500 and 400 MHz instruments. Chemical
data for protons and carbons were reported in parts per million (ppm)
downfield from tetramethylsilane and are referenced to the residual
proton and carbon in the NMR solvents (CDCl3: 7.26 ppm, 13C NMR solvents CDCl3: 77.0, acetone-d6: 206.6, 29.9 ppm). Electrospray ionization mass spectrometry
(ESI-MS) and high-resolution mass spectrometry (HRMS) spectra were
recorded on Agilent 1100 LC-Q-TOF and HRMS-6540-UHD machines. IR spectra
were recorded on an FTIR spectrophotometer with the absorption band
given in cm–1. Melting points were measured in a
digital melting point apparatus.

General Procedure for the
Synthesis of (Z)-2-(4-Cyano-furanyl)-3-hydroxy-acrylamides 3
To a 25 mL round bottomed flask equipped with a
magnetic bar, aroylacetonitrile 1 (0.689 mmol), arylglyoxal
monohydrate 2 (0.689 mmol) were dissolved in 2 mL of
toluene then added TEA (0.344 mmol) and TBHP in decane (0.754 mmol).
The reaction mixture was stirred at 75 °C for 4–6 h.
To determine the status of the reaction, it was monitored by thin-layer
chromatography. After completion, the reaction mixture was cooled
to room temperature, and 15 mL of water was added to the reaction
mixture and extracted with ethyl acetate (2 × 15 mL). The combined
organic layer was washed with brine solution, dried over Na2SO4, concentrated on a rotavap, and purified by column
chromatography by using ethyl acetate and hexane (1:4), producing
desired product 3 in good yields (45–76%).

Analytical
Data for Compounds 3
(Z)-2-(4-Cyano-2,5-diphenylfuran-3-yl)-3-hydroxy-3-phenylacrylamide 3a
White solid (106 mg, 76% yield). mp 235–238
°C. 1H NMR (CDCl3, 400 MHz): δ 15.75
(s, 1H), 8.00 (d, J = 8.0 Hz, 2H), 7.85 (d, J = 7.2 Hz, 2H), 7.49–7.45 (m, 5H), 7.42–7.38
(m, 3H), 7.29 (t, J = 7.2 Hz, 1H), 7.21 (t, J = 8.0 Hz, 2H), 5.51 (s, 2H). 13C NMR (125 MHz,
CDCl3): δ 174.9, 173.2, 158.3, 150.2, 134.5, 130.6,
130.4, 129.3, 129.2, 129.2, 128.4, 128.1, 128.0, 127.4, 125.4, 125.0,
117.5, 113.4, 97.0, 91.3. IR (CHCl3, cm–1) ν: 3468, 3360, 2923, 2851, 2226, 1641, 1489, 1445, 1415,
1330, 1156, 937, 768, 689. LC-MS (ESI) m/z: [M + H]+ calcd for C26H18N2O3, 407.1; found, 407.1; HRMS (TOF) m/z: [M + H]+ calcd for C26H18N2O3, 407.1390; found,
407.1375.

(Z)-2-(2-(4-Chlorophenyl)-4-cyano-5-phenylfuran-3-yl)-3-hydroxy-3-phenylacrylamide 3b
White solid (105 mg, 70% yield). mp 225–228
°C. 1H NMR (CDCl3, 400 MHz): δ 15.75
(s, 1H), 8.00 (d, J = 8.0 Hz, 2H), 7.76 (d, J = 8.8 Hz, 2H), 7.51 (m, 3H), 7.44 (d, J = 8.4 Hz, 2H), 7.36 (d, J = 7.2 Hz, 2H), 7.30 (t, J = 7.2 Hz, 1H), 7.22 (d, J = 7.6 Hz, 2H),
5.47 (s, 2H). 13C NMR (100 MHz, CDCl3): δ
175.2, 173.3, 158.6, 149.3, 135.4, 134.4, 131.5, 130.7, 130.5, 129.5,
129.2, 128.8, 128.1, 127.9, 127.3, 126.8, 126.2, 125.4, 117.9, 113.2,
97.2, 91.0. IR (CHCl3, cm–1) ν:
3359, 3063, 2955, 2923, 2852, 2227, 1691, 1648, 1573, 1490, 1447,
1403, 1326, 1277, 1180, 1094, 1013, 937, 832, 770, 691, 606. LC-MS
(ESI) m/z: [M + H]+ calcd
for C26H18ClN2O3, 441.1;
found, 441.1; HRMS (TOF) m/z: [M
+ H]+ calcd for C26H18ClN2O3, 441.1000; found, 441.0926.

(Z)-2-(2-(4-Bromophenyl)-4-cyano-5-phenylfuran-3-yl)-3-hydroxy-3-phenylacrylamide 3c
White solid (120 mg, 72% yield). mp 263–266
°C. 1H NMR (CDCl3, 400 MHz): δ 15.76
(s, 1H), 8.01 (d, J = 8.4 Hz, 2H), 7.70 (d, J = 8.4 Hz, 2H), 7.60 (d, J = 8.4 Hz, 2H),
7.52–7.47 (m, 3H), 7.37 (d, J = 6.8 Hz, 2H),
7.31 (t, J = 7.2 Hz, 1H), 7.23 (t, J = 7.2 Hz, 2H), 5.44 (s, 2H). 13C NMR (CDCl3, 100 MHz): δ 175.2, 173.2, 158.1, 149.3, 132.4, 130.7, 130.4,
129.2, 128.1, 127.8, 127.3, 126.4, 125.4, 123.6, 118.1, 113.2, 97.3,
91.0. IR (CHCl3, cm–1) ν: 3404,
2922, 2852, 2228, 1648, 1572, 1446, 1416, 1327, 1145, 938, 828, 768,
691. LC-MS (ESI) m/z: [M + H]+ calcd for C26H18BrN2O3, 485.1, 487.1; found, 485.1, 487.1; HRMS (TOF) m/z: [M + H]+ calcd for C26H18BrN2O3, 485.0495, 487.0479; found,
485.0498, 487.0482.

(Z)-2-(4-Cyano-2-(4-fluorophenyl)-5-phenylfuran-3-yl)-3-hydroxy-3-phenylacrylamide 3d
White solid (95 mg, 65% yield). mp 222–235
°C. 1H NMR (CDCl3, 400 MHz): δ 15.74
(s, 1H), 8.01 (d, J = 8.0 Hz, 2H), 7.81 (dd, J = 5.2, 3.2 Hz, 2H), 7.52–7.47 (m, 3H), 7.37 (d, J = 7.2 Hz, 2H), 7.31 (t, J = 6.4 Hz, 1H),
7.23–7.14 (m, 4H), 5.56 (s, 2H). 13C NMR (CDCl3, 100 MHz): δ 175.2, 173.4, 158.4, 149.6, 134.5, 130.6,
130.4, 129.2, 128.0, 127.8, 127.4, 127.2, 127.1, 125.4, 117.1, 116.5,
116.2, 113.3, 97.1, 91.1. IR (CHCl3, cm–1) ν: 3346, 3198, 2924, 2852, 2227, 1643, 1594, 1504, 1445,
1415, 1328, 1236, 1159, 938, 838, 768, 689. LC-MS (ESI) m/z: [M + H]+ calcd for C26H18FN2O3, 425.0; found, 425.0; HRMS
(TOF) m/z: [M + H]+ calcd
for C26H18FN2O3, 425.1296;
found, 425.1299.

(Z)-2-(4-Cyano-5-phenyl-2-(4-(trifluoromethyl)phenyl)furan-3-yl)-3-hydroxy-3-phenylacryl
amide 3e
Pale yellow solid (89 mg, 55% yield).
mp 238–241 °C. 1H NMR (CDCl3, 400
MHz): δ 15.78 (s, 1H), 8.04 (d, J = 8.0 Hz,
2H), 7.94 (d, J = 8.0 Hz, 2H), 7.73 (d, J = 8.4 Hz, 2H), 7.54–7.50 (m, 3H), 7.36 (d, J = 6.4 Hz, 2H), 7.32 (t, J = 7.6 Hz, 1H), 7.23 (t, J = 7.6 Hz, 2H), 5.52 (s, 2H). 13C NMR (CDCl3, 100 MHz): δ 175.4, 173.1, 159.2, 148.7, 134.4, 131.0,
130.5, 129.3, 128.1, 127.8, 127.1, 126.19, 126.15, 126.11, 125.5,
125.1, 119.6, 113.0, 97.4, 90.8. IR (CHCl3, cm–1) ν: 3347, 3198, 2921, 2851, 2228, 1647, 1554, 1490, 1324,
1236, 1124, 939, 829, 768, 688. LC-MS (ESI) m/z: [M + H]+ calcd for C27H18F3N2O3, 475.0; found, 475.0; HRMS
(TOF) m/z: [M + H]+ calcd
for C27H18F3N2O3, 475.1264; found, 475.1266.

(Z)-2-(4-Cyano-2-(4-nitrophenyl)-5-phenylfuran-3-yl)-3-hydroxy-3-phenylacrylamide 3f
Yellow solid (82 mg, 53% yield). mp 228–231
°C. 1H NMR (CDCl3, 400 MHz): δ 15.83
(s, 1H), 8.30 (d, J = 8.9 Hz, 2H), 8.03 (d, J = 7.8 Hz, 2H), 7.95 (d, J = 8.9 Hz, 2H),
7.53 (d, J = 5.1 Hz, 3H), 7.36–7.26 (m, 3H),
7.20 (t, J = 7.5 Hz, 2H), 5.51 (s, 2H). 13C NMR (CDCl3, 125 MHz): δ 175.6, 172.9, 159.8, 147.8,
147.4, 134.2, 133.9, 131.3, 130.7, 129.3, 128.2, 127.7, 126.9, 125.71,
125.4, 124.5, 121.3, 112.8, 97.8, 90.6. IR (CHCl3, cm–1) ν: 3349, 2923, 2852, 2229, 1600, 1520, 1491,
1446, 1418, 1343, 1110, 938, 853, 756, 693. LC-MS (ESI) m/z: [M + H]+ calcd for C26H18N3O5, 452.0; found, 452.0; HRMS
(TOF) m/z: [M + H]+ calcd
for C26H18N3O5, 452.1241;
found, 452.1216.

(Z)-2-(2-(Benzo[d][1,3]dioxol-5-yl)-4-cyano-5-phenylfuran-3-yl)-3-hydroxy-3-phenylacryl
amide 3g
White solid (105 mg, 68% yield). mp
223–226 °C. 1H NMR (CDCl3, 400 MHz):
δ 15.72 (s, 1H), 7.96 (d, J = 6.7 Hz, 2H),
7.51–7.43 (m, 3H), 7.42–7.34 (m, 3H), 7.32–7.27
(m, 2H), 7.22 (t, J = 7.4 Hz, 2H), 6.90 (d, J = 8.2 Hz, 1H), 6.04 (s, 2H), 5.48 (s, 2H). 13C NMR (CDCl3, 125 MHz): δ 174.9, 173.3, 157.7, 150.1,
148.6, 148.4, 134.5, 130.4, 129.1, 128.0, 127.9, 127.5, 125.2, 122.5,
119.7, 116.1, 113.4, 109.1, 105.4, 101.6, 97.0, 91.3. IR (CHCl3, cm–1) ν: 3386, 2923, 2852, 2228,
1642, 1448, 1446, 1418, 1253, 1035, 938, 853, 755, 690. LC-MS (ESI) m/z: [M + H]+ calcd for C27H19N2O5, 451.0; found, 451.0;
HRMS (TOF) m/z: [M + H]+ calcd for C27H19N2O5, 451.1288; found, 451.1289.

(Z)-2-(4-Cyano-2-(4-hydroxyphenyl)-5-phenylfuran-3-yl)-3-hydroxy-3-phenylacrylamide 3h
Pale brownish solid (84 mg, 58% yield). mp 232–235
°C. 1H NMR (CDCl3, 400 MHz): δ 16.69
(s, 1H), 8.90 (br s, 1H), 8.02 (d, J = 7.6 Hz, 2H),
7.76 (d, J = 8.4 Hz, 2H), 7.56–7.43 (m, 5H),
7.30–7.25 (m, 2H), 7.05–6.92 (m, 3H). 13C
NMR (acetone-d6, 100 MHz): δ 174.5,
173.9, 158.4, 156.8, 151.3, 135.5, 131.8, 130.0, 129.8, 129.2, 128.1,
127.8, 127.7, 126.9, 124.8, 120.8, 115.9, 113.8, 97.4, 92.0. IR (CHCl3, cm–1) ν: 3349, 2923, 2852, 2229,
1600, 1520, 1446, 1418, 1343, 1110, 938, 853, 756, 693; HRMS (TOF) m/z: [M + H]+ calcd for C26H19N2O4, 423.1339; found,
423.1344.

(Z)-2-(4-Cyano-2-(3,4-dimethylphenyl)-5-phenylfuran-3-yl)-3-hydroxy-3-phenylacrylamide 3i
White solid (92 mg, 62% yield). mp 231–234
°C. 1H NMR (CDCl3, 400 MHz): δ 15.71
(s, 1H), 7.98 (d, J = 6.8 Hz, 2H), 7.59 (d, J = 4.8 Hz, 2H), 7.49–7.40 (m, 5H), 7.29 (t, J = 8.8 Hz, 1H), 7.30–7.27 (m, 2H), 5.46 (s, 2H),
2.33 (s, 3H), 2.31 (s, 3H). 13C NMR (CDCl3,
100 MHz): δ 174.8, 173.4, 157.9, 150.7, 138.4, 137.5, 134.7,
130.4, 130.37, 130.32, 129.1, 128.06, 128.03, 127.6, 126.1, 126.0,
125.3, 122.6, 116.6, 113.5, 97.0, 91.5, 20.0, 19.7. IR (CHCl3, cm–1) ν: 3347, 3019, 2921, 2851, 2227,
1643, 1573, 1492, 1448, 1445, 1327, 1150, 954, 853, 756, 689. LC-MS
(ESI) m/z: [M + H]+ calcd
for C28H23N2O3, 435.0;
found, 435.0; HRMS (TOF) m/z: [M
+ H]+ calcd for C28H23N2O3, 435.1703; found, 435.1699.

(Z)-2-(4-Cyano-5-phenyl-2-(p-tolyl)furan-3-yl)-3-hydroxy-3-phenylacrylamide 3j
White solid (103 mg, 73% yield). mp 254–256 °C. 1H NMR (CDCl3, 400 MHz): δ 15.73 (s, 1H),
8.00 (t, J = 8.4 Hz, 2H), 7.76 (d, J = 8.0 Hz, 2H), 7.50–7.40 (m, 5H), 7.30–7.27 (m, 3H),
7.23 (d, J = 7.6 Hz, 2H), 5.44 (s, 2H), 2.42 (s,
3H). 13C NMR (CDCl3, 100 MHz): δ 174.9,
173.4, 158.0, 150.6, 139.6, 130.4, 130.3, 129.9, 129.1, 128.03, 128.01,
125.7, 125.3, 125.0, 116.7, 113.4, 97.0, 91.4, 21.4. IR (CHCl3, cm–1) ν: 3458, 3310, 2921, 2851,
2224, 1648, 1572, 1446, 1411, 1322, 1114, 937, 770, 687. LC-MS (ESI) m/z: [M + H]+ calcd for C27H21N2O3, 421.0; found, 421.0;
HRMS (TOF) m/z: [M + H]+ calcd for C27H21N2O3, 421.1547; found, 421.1527.

(Z)-2-(4-Cyano-5-phenyl-2-(o-tolyl)furan-3-yl)-3-hydroxy-3-phenylacrylamide 3k
White solid (93 mg, 62% yield). mp 234–236 °C. 1H NMR (CDCl3, 400 MHz): δ 15.47 (s, 1H),
8.01 (d, J = 8.2 Hz, 2H), 7.55–7.43 (m, 3H),
7.30–7.24 (m, 3H), 7.18–7.12 (m, 3H), 7.08 (t, J = 9.3 Hz, 3H), 5.56 (s, 2H), 1.97 (s, 3H). 13C NMR (125 MHz, CDCl3): δ 175.4, 173.9, 159.0, 152.9,
137.1, 134.9, 130.9, 130.5, 129.87, 129.85, 129.7, 129.2, 129.1, 128.6,
127.92, 127.91, 127.6, 126.0, 125.2, 118.6, 114.0, 95.8, 91.3, 20.2.
IR (CHCl3, cm–1) ν: 3417, 2924,
2852, 2226, 1643, 1448, 1418, 1326, 1180, 938, 829, 768, 691; HRMS
(TOF) m/z: [M + H]+ calcd
for C27H21N2O3, 4218.1543;
found, 421.1496.

(Z)-2-(4-Cyano-2-(4-ethylphenyl)-5-phenylfuran-3-yl)-3-hydroxy-3-phenylacrylamide 3l
White solid (112 mg, 75% yield). mp 239–242
°C. 1H NMR (CDCl3, 400 MHz): δ 15.65
(s, 1H), 7.92 (d, J = 8.4 Hz, 2H), 7.70 (d, J = 8.4 Hz, 2H), 7.42–7.36 (m, 3H), 7.34 (d, J = 7.2 Hz, 2H), 7.22–7.18 (m, 3H), 7.14 (t, J = 8.0 Hz, 2H), 5.46 (s, 2H), 2.66 (q, J = 7.6 Hz, 2H), 1.22 (t, J = 8.4 Hz, 3H). 13C NMR (CDCl3, 100 MHz): δ 174.8, 173.9, 158.0, 150.6,
145.9, 134.6, 130.9, 130.3, 129.1, 128.7, 127.6, 125.9, 125.3, 125.1,
116.7, 113.5, 97.0, 91.5, 28.7, 15.2. IR (CHCl3, cm–1) ν: 3469, 3337, 3188, 3063, 2966, 2931, 2227,
1644, 1572, 1491, 1445, 1415, 1328, 1286, 1151, 938, 837, 767, 689.
LC-MS (ESI) m/z: [M + H]+ calcd for C28H23N2O3, 435.0; found, 435.0; HRMS (TOF) m/z: [M + H]+ calcd for C28H23N2O3, 435.1703; found, 435.1691.

(Z)-2-(4-Cyano-2-phenyl-5-(p-tolyl)furan-3-yl)-3-hydroxy-3-(p-tolyl)acrylamide 3m
White solid
(107 mg, 72% yield). mp 202–205
°C. 1H NMR (CDCl3, 400 MHz): δ 15.73
(s, 1H), 7.92 (d, J = 8.4 Hz, 2H), 7.86 (d, J = 8.8 Hz, 2H), 7.49 (t, J = 7.2 Hz, 2H),
7.41 (t, J = 7.2 Hz, 1H), 7.32 (m, 4H), 7.01 (t, J = 8.4 Hz, 2H), 5.44 (s, 2H), 2.42 (m, 3H), 2.42 (m, 3H). 13C NMR (CDCl3, 100 MHz): δ 175.0, 173.4,
158.6, 149.8, 141.0, 140.6, 131.8, 129.8, 129.1, 128.7, 128.6, 127.9,
125.4, 124.99, 124.94, 117.7, 113.5, 96.4, 90.9, 21.5, 21.3. IR (CHCl3, cm–1) ν: 3469, 3337, 3188, 3063,
2966, 2931, 2227, 1644, 1572, 1491, 1445, 1415, 1328, 1286, 1151,
938, 837, 767, 689. LC-MS (ESI) m/z: [M + H]+ calcd for C28H23N2O3, 435.0; found, 435.0; HRMS (TOF) m/z: [M + H]+ calcd for C28H22N2O3, 435.1703; found, 435.1721.

(Z)-3-(4-Bromophenyl)-2-(5-(4-bromophenyl)-4-cyano-2-phenylfuran-3-yl)-3-hydroxyacryl
amide 3n
Pale yellow solid (135 mg, 70% yield).
mp 207–210 °C. 1H NMR (CDCl3, 400
MHz): δ 15.79 (s, 1H), 7.87 (d, J = 8.4 Hz,
2H), 7.80 (d, J = 7.2 Hz, 2H), 7.63 (d, J = 8.4 Hz, 2H), 7.49 (m, 3H), 7.34 (d, J = 8.4 Hz,
2H), 7.23 (d, J = 8.4 Hz, 2H), 5.53 (s, 2H). 13C NMR (CDCl3, 100 MHz): δ 173.8, 173.1,
157.4, 150.7, 133.4, 132.5, 131.4, 129.7, 129.5, 129.3, 128.1, 126.7,
126.2, 126.1, 125.1, 125.0, 117.2, 113.1, 97.3, 91.4. IR (CHCl3, cm–1) ν: 3345, 2923, 2852, 2227,
1620, 1483, 1419, 1323, 1152, 1071, 935, 828, 758, 690. LC-MS (ESI) m/z: [M + H]+ calcd for C26H17Br2N2O3, 564.0;
found, 564.0; HRMS (TOF) m/z: [M
+ H]+ calcd for C26H17Br2N2O3, 562.9600; found, 562.9579.

(Z)-3-(3-Chlorophenyl)-2-(5-(3-chlorophenyl)-4-cyano-2-phenylfuran-3-yl)-3-hydroxyacryl
amide 3o
Pale yellow solid (107 mg, 65% yield).
mp 188–190 °C. 1H NMR (CDCl3, 400
MHz): δ 15.74 (s, 1H), 7.93 (s, 1H), 7.91 (t, J = 6.0 Hz, 1H), 7.79 (d, J = 7.2 Hz, 2H), 7.50–7.42
(m, 5H), 7.34 (s, 1H), 7.26 (d, J = 7.2 Hz, 1H),
7.18 (d, J = 7.6 Hz, 1H), 7.12 (t, J = 8.0 Hz, 1H), 5.59 (s, 2H). 13C NMR (CDCl3, 100 MHz): δ 173.4, 173.2, 156.8, 151.3, 136.1, 135.4, 134.2,
130.6, 130.5, 130.4, 129.8, 129.3, 129.1, 128.9, 128.1, 128.0, 125.9,
125.2, 123.5, 117.0, 112.9, 97.9, 91.8. IR (CHCl3, cm–1) ν: 3345, 3069, 3021, 2923, 2852, 2229, 1643,
1553, 1475, 1426, 1322, 1156, 942, 756, 694. LC-MS (ESI) m/z: [M + H]+ calcd for C26H17Cl2N2O3, 475.0; found,
475.0; HRMS (TOF) m/z: [M + H]+ calcd for C26H17Cl2N2O3, 475.0611; found, 475.0594.

(Z)-3-(4-Chlorophenyl)-2-(5-(4-chlorophenyl)-4-cyano-2-phenylfuran-3-yl)-3-hydroxyacryl
amide 3p
Pale brownish solid (117 mg, 72% yield).
mp 210–213 °C. 1H NMR (CDCl3, 400
MHz): δ 15.77 (s, 1H), 7.96 (t, J = 8.8 Hz,
2H), 7.82 (d, J = 7.2 Hz, 2H), 7.51–7.41 (m,
5H), 7.33 (d, J = 7.6 Hz, 2H), 7.20 (d, J = 8.4 Hz, 2H), 5.52 (s, 2H). 13C NMR (CDCl3, 100 MHz): δ 173.8, 173.1, 157.3, 150.6, 136.8, 133.0, 129.6,
129.5, 129.3, 128.4, 128.1, 126.6, 125.8, 125.0, 117.2, 113.1, 97.3,
91.4. IR (CHCl3, cm–1) ν: 3339,
2921, 2851, 2228, 1642, 1486, 1419, 1324, 1271, 1093, 1013, 935, 833,
757, 691. LC-MS (ESI) m/z: [M +
H]+ calcd for C26H17Cl2N2O3, 475.0; found, 475.0; HRMS (TOF) m/z: [M + H]+ calcd for C26H17Cl2N2O3, 475.0611;
found, 475.0586.

(Z)-2-(2-(3-Bromophenyl)-4-cyano-5-(p-tolyl)furan-3-yl)-3-hydroxy-3-(p-tolyl)acrylamide 3q
White solid (113 mg, 65% yield). mp 222–235
°C. 1H NMR (CDCl3, 400 MHz): δ 15.64
(s, 1H), 7.82 (d, J = 8.0 Hz, 2H), 7.74 (dd, J = 5.6, 2.4 Hz, 2H), 7.22–7.18 (m, 5H), 7.09 (t, J = 8.4 Hz, 2H), 6.90 (d, J = 8.0 Hz, 2H),
5.38 (s, 2H), 2.34 (s, 3H), 2.18 (s, 3H). 13C NMR (CDCl3, 100 MHz): δ 175.2, 173.4, 158.7, 149.0, 141.1, 140.7,
131.7, 129.8, 128.7, 127.9, 127.08, 127.00, 125.3, 124.8, 117.3, 116.4,
116.2, 113.5, 96.4, 90.6, 21.5, 21.3. IR (CHCl3, cm–1) ν: 3346, 3206, 2922, 2851, 2227, 1642, 1614,
1504, 1418, 1328, 1184, 1150, 1116, 1020, 941, 821, 763, 688. LC-MS
(ESI) m/z: [M + H]+ calcd
for C28H21BrN2O3, 513.0,
515.0; found, 513.0, 515.0; HRMS (TOF) m/z: [M + H]+ calcd for C28H21BrN2O3, 513.0808, 515.0788; found, 513.0793,
515.0783.

(Z)-2-(4-Cyano-2,5-di-p-tolylfuran-3-yl)-3-hydroxy-3-(p-tolyl)acrylamide 3r
White solid
(115 mg, 74% yield). mp 214–216 °C. 1H NMR
(CDCl3, 400 MHz): δ 15.72 (s, 1H), 7.91 (d, J = 8.0 Hz, 2H), 7.77 (d, J = 8.0 Hz, 2H),
7.34–7.27 (m, 7H), 7.02 (d, J = 8.0 Hz, 2H),
5.47 (s, 2H), 2.427 (s 3H), 21.421 (s, 3H), 2.27 (s, 3H). 13C NMR (CDCl3, 100 MHz): δ 174.8, 173.5, 158.3, 150.0,
140.9, 140.6, 139.4, 131.8, 129.89, 129.81, 128.7, 128.0, 125.9, 125.3,
125.0, 124.9, 116.9, 113.6, 96.3, 91.0, 21.8, 21.39, 21.38. IR (CHCl3, cm–1) ν: 3342, 3031, 2922, 2852,
2227, 1643, 1613, 1504, 1418, 1329, 1184, 1116, 941, 821, 758, 688.
LC-MS (ESI) m/z: [M + H]+ calcd for C29H25N2O3, 449.0; found, 449.0; HRMS (TOF) m/z: [M + Na]+ calcd for C29H24N2NaO3, 471.1679; found, 471.1674.

(Z)-3-(4-Bromophenyl)-2-(5-(4-bromophenyl)-2-(4-chlorophenyl)-4-cyanofuran-3-yl)-3-hydroxyacrylamide 3s
Pale brown solid (138 mg, 68% yield). mp 203–206
°C. 1H NMR (CDCl3, 400 MHz): δ 15.70
(s, 1H), 7.79 (d, J = 8.4 Hz, 2H), 7.66 (d, J = 8.8 Hz, 2H), 7.42–7.36 (m, 3H), 7.34 (d, J = 7.2 Hz, 2H), 7.22–7.18 (m, 3H), 7.14 (t, J = 8.0 Hz, 2H), 5.46 (s, 2H), 2.66 (q, J = 7.6 Hz, 2H), 1.22 (t, J = 8.4 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ 174.1, 173.0, 157.6, 149.6,
135.8, 133.2, 132.5, 131.5, 129.6, 129.4, 126.8, 126.5, 126.2, 126.0,
125.3, 125.1, 117.6, 112.9, 97.4, 91.1. IR (CHCl3, cm–1) ν: 3356, 2923, 2851, 2228, 1649, 1483, 1419,
1323, 1010, 935, 830, 762. LC-MS (ESI) m/z: [M – H]+ calcd for C26H14Br2ClN2O3, 595.0, 597.0;
found, 595.0, 597.0; HRMS (TOF) m/z: [M + H]+ calcd for C26H16Br2ClN2O3, 596.9211, 598.9190; found, 596.9212,
598.9193.

(Z)-2-(4-Cyano-2-(4-fluorophenyl)-5-(p-tolyl)furan-3-yl)-3-hydroxy-3-(p-tolyl)acrylamide 3t
White solid (98 mg, 63% yield). mp 212–215
°C. 1H NMR (CDCl3, 400 MHz): δ 15.64
(s, 1H), 7.82 (d, J = 8.0 Hz, 2H), 7.74 (dd, J = 5.6, 2.4 Hz, 2H), 7.22–7.18 (m, 5H), 7.09 (t, J = 8.4 Hz, 2H), 6.90 (d, J = 8.0 Hz, 2H),
5.38 (s, 2H), 2.34 (s, 3H), 2.18 (s, 3H). 13C NMR (CDCl3, 100 MHz): δ 175.2, 173.4, 158.7, 149.0, 141.1, 140.7,
131.7, 129.8, 128.7, 127.9, 127.08, 127.00, 125.3, 124.8, 117.3, 116.4,
116.2, 113.5, 96.4, 90.6, 21.5, 21.3. IR (CHCl3, cm–1) ν: 3477, 3345, 3196, 2922, 2852, 2226, 1615,
1500, 1417, 1327, 1235, 1159, 1020, 935, 838, 756, 667. LC-MS (ESI) m/z: [M + H]+ calcd for C28H22FN2O3, 453.0; found,
453.0; HRMS (TOF) m/z: [M + H]+ calcd for C28H22FN2O3, 453.1609; found, 453.1649.

(Z)-3-(4-Chlorophenyl)-2-(5-(4-chlorophenyl)-4-cyano-2-(p-tolyl)furan-3-yl)-3-hydroxyacryl amide 3u
Pale brown solid (110 mg, 65% yield). mp 210–212
°C. 1H NMR (CDCl3, 400 MHz): δ 15.66
(s, 1H), 7.86 (d, J = 8.8 Hz, 2H), 7.64 (d, J = 8.0 Hz, 2H), 7.39 (d, J = 8.8 Hz, 2H),
7.25–7.18 (m, 4H), 7.11 (d, J = 8.8 Hz, 2H),
5.47 (s, 2H), 2.34 (s, 3H). 13C NMR (CDCl3,
100 MHz): δ 173.6, 173.2, 157.0, 150.9, 140.0, 136.6, 136.5,
133.0, 130.0, 129.5, 129.4, 128.4, 126.5, 125.9, 125.0, 116.4, 113.2,
97.2, 91.6, 21.4. IR (CHCl3, cm–1) ν:
3473, 3346, 3202, 2922, 2852, 2227, 1642, 1486, 1418, 1325, 1178,
1093, 1013, 935, 832, 757, 677. LC-MS (ESI) m/z: [M + H]+ calcd for C27H19ClN2O3, 489.0; found, 489.0; HRMS (TOF) m/z: [M + H]+ calcd for C27H19ClN2O3, 489.0767; found,
489.0807.

(Z)-2-(4-Cyano-5-phenyl-2-(thiophen-2-yl)furan-3-yl)-3-hydroxy-3-phenylacrylamide 3v
Pale brown solid (65 mg, 46% yield). mp 189–191
°C. 1H NMR (CDCl3, 400 MHz): δ 15.74
(s, 1H), 7.98 (d, J = 7.2 Hz, 2H), 7.72 (s, 1H),
7.51–7.44 (m, 5H), 7.40 (d, J = 7.2 Hz, 2H),
7.29 (t, J = 8.4 Hz, 1H), 7.23 (t, J = 7.2 Hz, 2H), 5.50 (s, 2H). 13C NMR (CDCl3, 100 MHz): δ 175.4, 173.4, 157.9, 148.3, 134.5, 130.5, 130.4,
129.5, 129.1, 128.4, 128.09, 128.00, 127.8, 127.2, 125.3, 124.6, 122.9,
116.2, 113.4, 96.6, 90.8. IR (CHCl3, cm–1) ν: 3346, 3110, 2924, 2853, 2228, 1667, 1509, 1448, 1415,
1264, 1178, 1074, 929, 842, 756, 690; HRMS (TOF) m/z: [M + H]+ calcd for C24H17N2O3S, 413.0954; found, 413.0956.

(Z)-2-(2-(5-Chlorothiophen-2-yl)-4-cyano-5-phenylfuran-3-yl)-3-hydroxy-3-phenylacryl
amide 3w
White solid (83 mg, 55% yield). mp
203–206 °C. 1H NMR (400 MHz, CDCl3): δ 15.86 (s, 1H), 7.97 (d, J = 7.7 Hz, 2H),
7.53–7.45 (m, 3H), 7.41 (d, J = 7.3 Hz, 2H),
7.34–7.28 (m, 1H), 7.29–7.19 (m, 3H), 6.93 (d, J = 3.9 Hz, 1H), 5.50 (s, 1H). 13C NMR (101 MHz,
CDCl3): δ 176.3, 173.2, 158.3, 146.4, 134.4, 132.7,
130.8, 130.6, 129.2, 128.2, 128.1, 127.8, 127.1, 126.9, 125.4, 124.6,
116.3, 113.2, 96.8, 89.8. IR (CHCl3, cm–1) ν: 3395, 2921, 2851, 2229, 1649, 1454, 1415, 1267, 1146,
1114, 980, 771, 672. LC-MS (ESI) m/z: [M + H]+ calcd for C24H16ClN2O3S, 447.0; found, 447.0; HRMS (TOF) m/z: [M + H]+ calcd for C24H16ClN2O3S, 447.0565; found, 447.0551.

(Z)-2-(2-(5-Bromothiophen-2-yl)-4-cyano-5-phenylfuran-3-yl)-3-hydroxy-3-phenylacryl
amide 3x
Pale brown solid (108 mg, 65% yield).
mp 190–194 °C. 1H NMR (CDCl3, 400
MHz): δ 15.91 (s, 1H), 8.01 (d, J = 8.4 Hz,
2H), 7.45 (d, J = 7.2 Hz, 2H), 7.36 (t, J = 7.2 Hz, 1H), 7.29 (d, J = 8.8 Hz, 2H), 7.25 (d, J = 4.0 Hz, 1H), 7.10 (d, J = 4.0 Hz, 1H),
5.46 (s, 2H). 13C NMR (CDCl3, 100 MHz): δ
176.3, 173.2, 158.3, 146.4, 134.4, 131.1, 130.8, 130.7, 130.6, 129.2,
128.1, 127.8, 127.1, 125.5, 125.4, 116.5, 115.2, 113.2, 96.8, 89.8.
IR (CHCl3, cm–1) ν: 3345, 3194,
3059, 2923, 2851, 2228, 1643, 1572, 1490, 1444, 1406, 1328, 1263,
1150, 1028, 967, 798, 768, 688; HRMS (TOF) m/z: [M + H]+ calcd for C24H16BrN2O3S, 491.0060, 493.0039; found, 490.9960,
492.9952.

(Z)-2-(2-(5-Bromothiophen-2-yl)-4-cyano-5-(p-tolyl)furan-3-yl)-3-hydroxy-3-(p-tolyl)acryl
amide 3y
White solid (110 mg, 63% yield). mp
233–236 °C. 1H NMR (CDCl3, 400 MHz):
δ 15.90 (s, 1H), 7.91 (d, J = 8.0 Hz, 2H),
7.35 (m, 4H), 7.24 (d, J = 4.0 Hz, 1H), 7.09–7.05
(m, 3H), 5.40 (s, 2H), 2.45 (s, 3H), 2.30 (s, 3H). 13C
NMR (101 MHz, CDCl3): δ 176.3, 173.2, 141.4, 140.9,
131.3, 130.6, 129.9, 128.8, 127.8, 125.3, 125.2, 124.5, 119.4, 115.0,
113.4, 96.1, 94.7, 21.6, 21.4. IR (CHCl3, cm–1) ν: 3362, 2922, 2851, 2229, 1681, 1605, 1503, 1453, 1250,
1185, 976, 869, 820, 754, 720, 673; HRMS (TOF) m/z: [M + H]+ calcd for C26H20BrN2O3S, 519.0373, 521.0352; found, 519.0327,
521.0313.

(Z)-2-(2-(5-Bromothiophen-2-yl)-5-(4-chlorophenyl)-4-cyanofuran-3-yl)-3-(4-chlorophenyl)-3-hydroxyacrylamide 3z
Pale brown solid (99 mg, 53% yield). mp 235–238
°C. 1H NMR (CDCl3, 400 MHz): δ 15.92
(s, 1H), 7.92 (d, J = 8.4 Hz, 2H), 7.48 (d, J = 8.8 Hz, 2H), 7.34 (d, J = 8.8 Hz, 2H),
7.23–7.21 (m, 3H), 7.08 (d, J = 3.6 Hz, 1H),
5.46 (s, 2H). 13C NMR (100 MHz, CDCl3): δ
175.1, 173.0, 157.3, 146.7, 137.0, 136.8, 132.7, 130.8, 130.6, 129.6,
129.2, 128.6, 126.6, 125.8, 125.4, 116.0, 115.7, 112.9, 96.9, 89.9.
IR (CHCl3, cm–1) ν: 3334, 2957,
2924, 2852, 2230, 1649, 1589, 1486, 1405, 1320, 1259, 1174, 1093,
1013, 980, 834, 757, 610; HRMS (TOF) m/z: [M + H]+ calcd for C24H14BrCl2N2O3S, 558.9280, 560.9260; found, 558.9204,
560.9211.

(Z)-3-(4-Bromophenyl)-2-(5-(4-bromophenyl)-2-(5-bromothiophen-2-yl)-4-cyanofuran-3-yl)-3-hydroxyacrylamide 3aa
White solid (128 mg, 58% yield). mp 252–255
°C. 1H NMR (CDCl3, 400 MHz): δ 15.93
(s, 1H), 7.84 (d, J = 8.8 Hz, 2H), 7.64 (d, J = 8.8 Hz, 2H), 7.39 (d, J = 8.8 Hz, 1H),
7.27–7.25 (m, 5H), 7.22 (d, J = 4.0 Hz, 1H),
5.39 (s, 2H). 13C NMR (126 MHz, acetone-d6): δ 174.3, 174.0, 156.9, 146.7, 134.2, 131.4,
131.4, 131.1, 129.6, 126.8, 126.6, 126.1, 124.3, 124.2, 116.6, 114.1,
113.2, 97.6, 90.3, 78.3. IR (CHCl3, cm–1) ν: 3396, 2921, 2850, 2227, 1649, 1454, 1249, 1215, 1010,
827, 755, 666; HRMS (TOF) m/z: [M
+ H]+ calcd for C24H14Br3N2O3S, 648.8249, 650.8229; found, 648.8193,
650.8179.

Supporting Information Available
The Supporting Information is
available free of charge on the ACS Publications website at DOI: 10.1021/acsomega.8b00715.Experimental procedures,
details for control experiments,
characterization data, and 1H and 13C NMR spectra
(PDF)

X-ray
crystallographic data for 3f (CIF)

X-ray crystallographic data for 3n (CIF)



Supplementary Material
ao8b00715_si_001.pdf

 ao8b00715_si_002.cif

 ao8b00715_si_003.cif

 The authors
declare no competing financial interest.

Acknowledgments
N.M.
thanks CSIR for awarding the Research Associate
fellowship, and S.K. thanks DST for the award of SRF and AcSIR for
Ph.D. registration. This work was generously supported by CSIR network
project through grant no. HCP-0008 (IIIM/2214/2018).
==== Refs
References
a Wender P. A. ; Verma V. A. ; Paxton T. J. ; Pillow T. H. 
Function-Oriented
Synthesis, Step Economy, and Drug Design . Acc.
Chem. Res. 
2008 , 41 , 40 –49 . 10.1021/ar700155p .18159936  b Trost B. M. 
The atom economy—a search for synthetic efficiency . Science 
1991 , 254 , 1471 –1477 . 10.1126/science.1962206 .1962206  c Hayashi Y. 
Pot economy and one-pot synthesis . Chem. Sci. 
2016 , 7 , 866 –880 . 10.1039/c5sc02913a .28791118  d Parsons P. J. ; Penkett C. S. ; Shell A. J. 
Tandem Reactions
in Organic Synthesis: Novel Strategies for Natural Product Elaboration
and the Development of New Synthetic Methodology . Chem. Rev. 
1996 , 96 , 195 –206 . 10.1021/cr950023+ .11848750  e Anastas P. ; Eghbali N. 
Green Chemistry: Principles and Practice . Chem. Soc. Rev. 
2010 , 39 , 301 –312 . 10.1039/b918763b .20023854  f Grondal C. ; Jeanty M. ; Enders D. 
Organocatalytic cascade
reactions as a new tool in total synthesis . Nat. Chem. 
2010 , 2 , 167 –178 . 10.1038/nchem.539 .21124474  g Schinzer D. ; Bo Y. 
Synthesis of Heterocycles by Tandem
Reactions: Beckmann Rearrangements/Allylsilane Cyclizations . Angew. Chem., Int. Ed. 
1991 , 30 , 687 –688 . 10.1002/anie.199106871 . h Wasilke J.-C. ; Obrey S. J. ; Baker R. T. ; Bazan G. C. 
Concurrent
Tandem Catalysis . Chem. Rev. 
2005 , 105 , 1001 –1020 . 10.1021/cr020018n .15755083  i Trost B. M. 
Atom Economy—A
Challenge for Organic Synthesis: Homogeneous Catalysis Leads the Way . Angew. Chem., Int. Ed. 
1995 , 34 , 259 –281 . 10.1002/anie.199502591 .
a Hussain M. M. ; Walsh P. J. 
Tandem Reactions
for Streamlining
Synthesis: Enantio- and Diastereoselective One-Pot Generation of Functionalized
Epoxy Alcohols . Acc. Chem. Res. 
2008 , 41 , 883 –893 . 10.1021/ar800006h .18710197  b Newhouse T. ; Baran P. S. ; Hoffmann R. W. 
The economies of synthesis . Chem. Soc. Rev. 
2009 , 38 , 3010 –3021 . 10.1039/b821200g .19847337  c Hummel J. R. ; Ellman J. A. 
Cobalt(III)-Catalyzed
Synthesis of Indazoles and Furans by C–H Bond Functionalization/Addition/Cyclization
Cascades . J. Am. Chem. Soc. 
2015 , 137 , 490 –498 . 10.1021/ja5116452 .25494296  d Liu M.-x. ; Li J.-r. ; Zheng K. ; Yao H. ; Zhang Q. ; Shi D.-x. 
Base-catalyzed one-pot tandem reaction: an effective
strategy for the synthesis of pyrazolo[3,4-d]pyrimidinone derivatives . Tetrahedron 
2015 , 71 , 7658 –7662 . 10.1016/j.tet.2015.07.065 . e Reddy C. R. ; Reddy M. D. 
A Metal-Free Tandem C–C/C–O
Bond Formation Approach to Diversely Functionalized Tetrasubstituted
Furans . J. Org. Chem. 
2014 , 79 , 106 –116 . 10.1021/jo4023342 .24325266 
a Mortensen D. S. ; Rodriguez A. L. ; Carlson K. E. ; Sun J. ; Katzenellenbogen B. S. ; Katzenellenbogen J. A. 
Synthesis and Biological Evaluation
of a Novel Series of Furans: Ligands Selective for Estrogen Receptor
α . J. Med. Chem. 
2001 , 44 , 3838 –3848 . 10.1021/jm010211u .11689070 b Feng Z. ; Jia J. ; Liu Y. ; Wang Z. ; Zhao X.  3-Furyl-2-cyano-2-acrylamide Derivative, Preparation
Method Therefor, Pharmaceutical Composition and Use Thereof . WO/2015/081822 , 2015 . c Boykin D. W. 
Antimicrobial Activity of the DNA
Minor Groove Binders Furamidine and Analogs . J. Braz. Chem. Soc. 
2002 , 13 , 763 –771 . 10.1590/s0103-50532002000600006 . d Wong H. N. C. ; Yu P. ; Yick C.-Y. 
The use of furans
in natural product syntheses . Pure Appl. Chem. 
1999 , 71 , 1041 –1044 . 10.1351/pac199971061041 . e Lee H.-K. ; Chan K.-F. ; Hui C.-W. ; Yim H.-K. ; Wu X.-W. ; Wong H. N. C. 
Use of furans in synthesis of bioactive compounds . Pure Appl. Chem. 
2005 , 77 , 139 –143 . 10.1351/pac200577010139 . f Farag A. A. 
N-(Furan-2-ylmethyl)-cyanoacetamide in heterocyclic
synthesis: Synthesis of novel antimicrobial agents encompassing furan,
pyridine, chromene, and chromenopyridine moieties . Der Pharma Chem. 
2015 , 7 , 130 –141 . g Ding L.-J. ; Gu B.-B. ; Jiao W.-H. ; Yuan W. ; Li Y.-X. ; Tang W.-Z. ; Yu H.-B. ; Liao X.-J. ; Han B.-N. ; Li Z.-Y. ; Xu S.-H. ; Lin H.-W. 
New Furan
and Cyclopentenone Derivatives from the Sponge-Associated Fungus Hypocrea
Koningii PF04 . Mar. Drugs 
2015 , 13 , 5579 –5592 . 10.3390/md13095579 .26343687  h Sauer B. ; Skinner-Adams T. S. ; Bouchut A. ; Chua M. J. ; Pierrot C. ; Erdmann F. ; Robaa D. ; Schmidt M. ; Khalife J. ; Andrews K. T. ; Sippl W. 
Synthesis, biological characterisation
and structure activity relationships of aromatic bisamidines active
against Plasmodium falciparum . Eur. J. Med.
Chem. 
2017 , 127 , 22 –40 . 10.1016/j.ejmech.2016.12.041 .28038325  i Lipshutz B. H. 
Five-membered heteroaromatic rings as intermediates
in organic synthesis . Chem. Rev. 
1986 , 86 , 795 10.1021/cr00075a005 .j Keay B. A. ; Dibble P. W.  Furans and
their Benzo Derivatives: Applications . Comprehensive
Heterocyclic Chemistry II ; Pergamon , 1996 ; Vol. 2 , pp 395 –436 .
a Battace A. ; Lemhadri M. ; Zair T. ; Doucet H. ; Santelli M. 
Palladium-Catalyzed
Direct Arylation of Furans via
C–H Functionalization at Low Catalyst Loadings . Organometallics 
2007 , 26 , 472 –474 . 10.1021/om0610243 . b Wang X. ; Liu J. ; Xu L. ; Hao Z. ; Wang L. ; Xiao J. 
Friedel–Crafts alkylation
of heteroarenes and arenes with indolyl alcohols for construction
of 3,3-disubstituted oxindoles . RSC Adv. 
2015 , 5 , 101713 –101717 . 10.1039/c5ra21919a . c Corey E. J. ; Xiang Y. B. 
A method for the off-ring functionalization of carbon-substituted
furans. Synthesis of kahweol from cafestol . Tetrahedron Lett. 
1987 , 28 , 5403 –5406 . 10.1016/s0040-4039(00)96739-x .
a Minetto G. ; Raveglia L. F. ; Taddei M. 
Microwave-Assisted
Paal–Knorr Reaction. A Rapid Approach to Substituted Pyrroles
and Furans . Org. Lett. 
2004 , 6 , 389 –392 . 10.1021/ol0362820 .14748600  b Rao H. S. P. ; Jothilingam S. 
Facile Microwave-Mediated Transformations of 2-Butene-1,4-diones
and 2-Butyne-1,4-diones to Furan Derivatives . J. Org. Chem. 
2003 , 68 , 5392 –5394 . 10.1021/jo0341766 .12816506  c Chen R. ; Fan X. ; Xu Z. ; He Z. 
Facile synthesis
of polysubstituted furans and dihydrofurans via cyclization of bromonitromethane
with oxodienes . Tetrahedron Lett. 
2017 , 58 , 3722 –3726 . 10.1016/j.tetlet.2017.08.027 .
a Feist F. 
Studien in der Furan-und Pyrrol-Gruppe.
I. Condensation
von β-Ketonsäureestern mit Chloraceton und Ammoniak . Ber. Dtsch. Chem. Ges. 
1902 , 35 , 1545 –1556 . 10.1002/cber.19020350264 . b Ghazvini M. ; Shahvelayati A. S. ; Sabri A. ; Nasrabadi F. Z. 
Synthesis of furan and dihydrofuran
derivatives via Feist–Benary reaction in the presence of ammonium
acetate in aqueous ethanol . Chem. Heterocycl.
Compd. 
2016 , 52 , 161 –164 . 10.1007/s10593-016-1854-2 . c Calter M. A. ; Phillips R. M. ; Flaschenriem C. 
Catalytic,
Asymmetric, “Interrupted” Feist–Bénary
Reactions . J. Am. Chem. Soc. 
2005 , 127 , 14566 –14567 . 10.1021/ja055752d .16231897 
a Moran W. J. ; Rodríguez A. 
Metal-catalyzed Furan Synthesis.
A Review . Org. Prep. Proced. Int. 
2012 , 44 , 103 –130 . 10.1080/00304948.2012.657558 . b Hosseyni S. ; Su Y. ; Shi X. 
Gold Catalyzed Synthesis of Substituted Furan by Intermolecular
Cascade Reaction of Propargyl Alcohol and Alkyne . Org. Lett. 
2015 , 17 , 6010 –6013 . 10.1021/acs.orglett.5b02980 .26634310  c Yang Y. ; Yao J. ; Zhang Y. 
Synthesis of Polysubstituted
Furans via Copper-Mediated Annulation of Alkyl Ketones with α,β-Unsaturated
Carboxylic Acids . Org. Lett. 
2013 , 15 , 3206 –3209 . 10.1021/ol400912v .23772562  d Ji J. ; Lu X. 
Facile synthesis of 2,5-disubstituted furans via palladium complex
and perfluorinated resinsulfonic acid catalysed isomerization–dehydration
of alkynediols . J. Chem. Soc., Chem. Commun. 
1993 , 764 –765 . 10.1039/c39930000764 . e Ghosh M. ; Mishra S. ; Hajra A. 
Regioselective Synthesis of Multisubstituted
Furans via Copper-Mediated Coupling between Ketones and β-Nitrostyrenes . J. Org. Chem. 
2015 , 80 , 5364 –5368 . 10.1021/acs.joc.5b00704 .25912976  f Jiang H. ; Zeng W. ; Li Y. ; Wu W. ; Huang L. ; Fu W. 
Copper(I)-Catalyzed
Synthesis of 2,5-Disubstituted Furans and Thiophenes from Haloalkynes
or 1,3-Diynes . J. Org. Chem. 
2012 , 77 , 5179 –5183 . 10.1021/jo300692d .22590973  g He C. ; Guo S. ; Ke J. ; Hao J. ; Xu H. ; Chen H. ; Lei A. 
Silver-Mediated Oxidative C–H/C–H Functionalization:
A Strategy To Construct Polysubstituted Furans . J. Am. Chem. Soc. 
2012 , 134 , 5766 –5769 . 10.1021/ja301153k .22428614  i Chobanov N. M. ; Shaibakova M. G. ; Popod’ko N. R. ; Khafizova L. O. ; Dzhemilev U. M. 
Ti-catalyzed reactions of unsymmetrical
alkynes with esters of monocarboxylic acids and EtAlCl2: An efficient
catalytic method for the synthesis of tetrasubstituted furans . Tetrahedron 
2017 , 73 , 5639 –5769 . 10.1016/j.tet.2017.07.045 . j Zhang X. ; Dai W. ; Wu W. ; Cao S. 
Copper-Catalyzed
Coupling Cyclization of gem-Difluoroalkenes with Activated Methylene
Carbonyl Compounds: Facile Domino Access to Polysubstituted Furans . Org. Lett. 
2015 , 17 , 2708 –2711 . 10.1021/acs.orglett.5b01123 .25988867  k Nguyen V.-H. ; Nishino H. ; Kurosawa K. 
Manganese(III)-Based
Facile Synthesis of 3-Cyano-4,5-dihydrofurans and 4-Cyano-1,2-dioxan-3-ols
Using Alkenes and Acylacetonitrile Building Blocks . Synthesis 
1997 , 899 –908 . 10.1055/s-1997-1282 . l Jiang H. ; Yao W. ; Cao H. ; Huang H. ; Cao D. 
Iron-Catalyzed Domino Process for the Synthesis of α-Carbonyl
Furan Derivatives via One-Pot Cyclization Reaction . J. Org. Chem. 
2010 , 75 , 5347 –5350 . 10.1021/jo100813w .20590131  m Payra S. ; Saha A. ; Guchhait S. ; Banerjee S. 
Direct CuO nanoparticle-catalyzed synthesis of poly-substituted
furans via oxidative C–H/C–H functionalization in aqueous
medium . RSC Adv. 
2016 , 6 , 33462 –33467 . 10.1039/c6ra04181g .
a Chen L. ; Du Y. ; Zeng X.-P. ; Shi T.-D. ; Zhou F. ; Zhou J. 
Successively Recycle Waste as Catalyst:
A One-Pot Wittig/1,4-Reduction/Paal–Knorr Sequence for Modular
Synthesis of Substituted Furans . Org. Lett. 
2015 , 17 , 1557 –1560 . 10.1021/acs.orglett.5b00442 .25730110  b Kao T.-T. ; Syu S.-e. ; Jhang Y.-W. ; Lin W. 
Preparation
of Tetrasubstituted Furans via Intramolecular Wittig Reactions with
Phosphorus Ylides as Intermediates . Org. Lett. 
2010 , 12 , 3066 –3069 . 10.1021/ol101080q .20521775  c Lee C.-J. ; Chang T.-H. ; Yu J.-K. ; Reddy G. M. ; Hsiao M.-Y. ; Lin W. 
Synthesis of Functionalized Furans via Chemoselective Reduction/Wittig
Reaction Using Catalytic Triethylamine and Phosphine . Org. Lett. 
2016 , 18 , 3758 –3761 . 10.1021/acs.orglett.6b01781 .27434727  d Chan C.-K. ; Chan Y.-L. ; Tsai Y.-L. ; Chang M.-Y. 
One-Pot
Synthesis of 2-Cyano-1,4-diketones: Applications to Synthesis of Cyanosubstituted
Furans, Pyrroles, and Dihydropyridazines . J.
Org. Chem. 
2016 , 81 , 8112 –8115 . 10.1021/acs.joc.6b01672 .27490960 
a Wang K.-K. ; Wang P. ; Ouyang Q. ; Dua W. ; Chen Y.-C. 
Substrate-controlled switchable asymmetric annulations
to access polyheterocyclic skeletons . Chem.
Commun. 
2016 , 52 , 11104 –11107 . 10.1039/c6cc06148f . b Deshpande S. J. ; Leger P. R. ; Sieck S. R. 
Microwave synthesis
of α-cyano chalcones . Tetrahedron Lett. 
2012 , 53 , 1772 –1775 . 10.1016/j.tetlet.2012.01.109 .
a Min J. ; Wang P. ; Srinivasan S. ; Nwachukwu J. C. ; Guo P. ; Huang M. ; Carlson K. E. ; Katzenellenbogen J. A. ; Nettles K. W. ; Zhou H.-B. 
Thiophene-Core Estrogen
Receptor Ligands Having Superagonist Activity . J. Med. Chem. 
2013 , 56 , 3346 –3366 . 10.1021/jm400157e .23586645  b Wynberg H. ; Sinnige H. J. M. ; Creemers H. M. J. C. 
Thienylfurans . J. Org. Chem. 
1971 , 36 , 1011 –1013 . 10.1021/jo00806a040 . c Barbarella G. ; Zangoli M. ; Maria F. D. 
Chapter Three—Synthesis and Applications of
Thiophene Derivatives as Organic Materials . Adv. Heterocycl. Chem. 
2017 , 123 , 105 –167 . 10.1016/bs.aihch.2017.01.001 .

